Showing results (921-930 of 945) with videos related to
Sort By:
Pageof 95
Nature Medicine|May 31, 2025
Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trialNeal D Shore, Thomas B Powles, Jens Bedke, et al.Nature Reviews. Urology|September 24, 2014
Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USASiamak Daneshmand, Anne K Schuckman, Bernard H Bochner, et al.Clinical Genitourinary Cancer|January 1, 2018
Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder CancerLauren C Harshman, Abhishek Tripathi, Matthew Kaag, et al.European Urology|October 4, 2025
Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the BladderAmanda A Myers, Ruchika Talwar, Zhigang Duan, et al.Nature Medicine|June 6, 2024
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trialRoger Li, Paras H Shah, Tyler F Stewart, et al.BMC Health Services Research|July 26, 2020
Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approachCheryl T Lee, Nihal E Mohamed, Sailaja Pisipati, et al.Nature Communications|April 18, 2023
The value of ecosystem services in global marine kelp forestsAaron M Eger, Ezequiel M Marzinelli, Rodrigo Beas-Luna, et al.European Urology|February 22, 2026
Optimal Management of Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer GroupShilpa Gupta, Roger Li, Patrick J Hensley, et al.Blood|August 1, 1982
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB studyJ Yates, O Glidewell, P Wiernik, et al.EJNMMI Research|July 26, 2013
Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reportingYung-Hsiang Kao, Jeffrey D Steinberg, Young-Soon Tay, et al.Pageof 95